Concepts (95)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hyperparathyroidism, Primary | 2 | 2020 | 33 | 1.310 |
Why?
|
| Time-to-Treatment | 2 | 2019 | 186 | 1.090 |
Why?
|
| Parathyroidectomy | 2 | 2023 | 49 | 0.720 |
Why?
|
| Trisomy 13 Syndrome | 1 | 2020 | 19 | 0.690 |
Why?
|
| Trisomy 18 Syndrome | 1 | 2020 | 16 | 0.690 |
Why?
|
| Life Support Care | 1 | 2020 | 48 | 0.670 |
Why?
|
| Cholecystitis, Acute | 1 | 2019 | 16 | 0.640 |
Why?
|
| Cholecystectomy | 1 | 2019 | 58 | 0.630 |
Why?
|
| Appendectomy | 1 | 2018 | 86 | 0.560 |
Why?
|
| Appendicitis | 1 | 2018 | 128 | 0.530 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 617 | 0.460 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2020 | 618 | 0.430 |
Why?
|
| Laparoscopy | 1 | 2018 | 491 | 0.400 |
Why?
|
| Veterans | 1 | 2019 | 1747 | 0.290 |
Why?
|
| Postoperative Complications | 1 | 2018 | 3055 | 0.250 |
Why?
|
| Parathyroid Glands | 1 | 2023 | 28 | 0.210 |
Why?
|
| Surgical Oncology | 1 | 2023 | 12 | 0.210 |
Why?
|
| Thyroid Gland | 1 | 2023 | 104 | 0.200 |
Why?
|
| Firearms | 1 | 2023 | 42 | 0.200 |
Why?
|
| Wilms Tumor | 1 | 2023 | 117 | 0.190 |
Why?
|
| Wounds, Gunshot | 1 | 2023 | 138 | 0.190 |
Why?
|
| Venous Thrombosis | 1 | 2023 | 166 | 0.180 |
Why?
|
| Suicide | 1 | 2023 | 178 | 0.170 |
Why?
|
| Blood Gas Analysis | 1 | 2020 | 86 | 0.170 |
Why?
|
| Parathyroid Hormone | 1 | 2020 | 73 | 0.170 |
Why?
|
| Thyroid Nodule | 1 | 2019 | 19 | 0.160 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2019 | 50 | 0.160 |
Why?
|
| Catheterization | 1 | 2020 | 228 | 0.160 |
Why?
|
| Kidney Neoplasms | 1 | 2023 | 440 | 0.150 |
Why?
|
| Patient Discharge Summaries | 1 | 2017 | 10 | 0.140 |
Why?
|
| Middle Aged | 5 | 2023 | 26827 | 0.140 |
Why?
|
| Comprehension | 1 | 2017 | 74 | 0.140 |
Why?
|
| Thyroid Neoplasms | 1 | 2019 | 189 | 0.140 |
Why?
|
| Male | 8 | 2023 | 61628 | 0.130 |
Why?
|
| Health Literacy | 1 | 2017 | 80 | 0.130 |
Why?
|
| Delphi Technique | 1 | 2017 | 210 | 0.130 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2020 | 669 | 0.130 |
Why?
|
| United States | 3 | 2023 | 10924 | 0.130 |
Why?
|
| Female | 7 | 2023 | 66888 | 0.120 |
Why?
|
| Humans | 10 | 2023 | 125439 | 0.120 |
Why?
|
| Patient Education as Topic | 1 | 2017 | 446 | 0.110 |
Why?
|
| Retrospective Studies | 3 | 2023 | 16362 | 0.110 |
Why?
|
| Aged | 3 | 2023 | 19739 | 0.110 |
Why?
|
| Registries | 1 | 2020 | 1434 | 0.110 |
Why?
|
| Treatment Outcome | 2 | 2020 | 12303 | 0.110 |
Why?
|
| Patient Discharge | 1 | 2017 | 497 | 0.110 |
Why?
|
| Databases, Factual | 1 | 2018 | 1174 | 0.100 |
Why?
|
| Prognosis | 2 | 2023 | 4690 | 0.100 |
Why?
|
| Comorbidity | 1 | 2018 | 1532 | 0.100 |
Why?
|
| Hospital Mortality | 1 | 2018 | 1027 | 0.100 |
Why?
|
| Length of Stay | 1 | 2018 | 1313 | 0.100 |
Why?
|
| Quality Improvement | 1 | 2018 | 647 | 0.100 |
Why?
|
| Histoplasma | 1 | 2010 | 31 | 0.090 |
Why?
|
| Cell Wall | 1 | 2010 | 40 | 0.090 |
Why?
|
| Glucosyltransferases | 1 | 2010 | 49 | 0.090 |
Why?
|
| Thyroidectomy | 2 | 2023 | 100 | 0.090 |
Why?
|
| Adult | 3 | 2019 | 29635 | 0.080 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 6558 | 0.080 |
Why?
|
| Infant, Newborn | 1 | 2020 | 8268 | 0.070 |
Why?
|
| Child | 3 | 2023 | 24606 | 0.070 |
Why?
|
| Risk Factors | 1 | 2019 | 10298 | 0.060 |
Why?
|
| Infant | 1 | 2020 | 12597 | 0.060 |
Why?
|
| Child, Preschool | 1 | 2020 | 14142 | 0.060 |
Why?
|
| Thrombectomy | 1 | 2023 | 92 | 0.050 |
Why?
|
| Vena Cava, Inferior | 1 | 2023 | 99 | 0.050 |
Why?
|
| Nephrectomy | 1 | 2023 | 178 | 0.050 |
Why?
|
| Population Surveillance | 1 | 2023 | 389 | 0.040 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2019 | 117 | 0.040 |
Why?
|
| Reading | 1 | 2017 | 79 | 0.030 |
Why?
|
| Continuity of Patient Care | 1 | 2017 | 153 | 0.030 |
Why?
|
| Consensus | 1 | 2017 | 644 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 3433 | 0.030 |
Why?
|
| Physician-Patient Relations | 1 | 2017 | 429 | 0.030 |
Why?
|
| Communication | 1 | 2017 | 515 | 0.030 |
Why?
|
| Surgeons | 1 | 2017 | 257 | 0.030 |
Why?
|
| Glucans | 1 | 2010 | 11 | 0.020 |
Why?
|
| 3T3 Cells | 1 | 2010 | 121 | 0.020 |
Why?
|
| Lectins, C-Type | 1 | 2010 | 71 | 0.020 |
Why?
|
| Histoplasmosis | 1 | 2010 | 48 | 0.020 |
Why?
|
| Virulence | 1 | 2010 | 264 | 0.020 |
Why?
|
| Species Specificity | 1 | 2010 | 551 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2010 | 381 | 0.020 |
Why?
|
| Texas | 1 | 2017 | 3582 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2019 | 6174 | 0.020 |
Why?
|
| RNA Interference | 1 | 2010 | 508 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2010 | 486 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2010 | 1338 | 0.020 |
Why?
|
| Macrophages | 1 | 2010 | 625 | 0.020 |
Why?
|
| Adolescent | 1 | 2023 | 19447 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2010 | 1128 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2010 | 3419 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2010 | 1538 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2010 | 4420 | 0.010 |
Why?
|
| Mice | 1 | 2010 | 17744 | 0.010 |
Why?
|
| Animals | 1 | 2010 | 34310 | 0.000 |
Why?
|